Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474. [PDF]
Br J Pharmacol, 2020 Bonifácio MJ +8 more
europepmc +1 more source
Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. [PDF]
BMC Neurosci, 2014 Sierra-Paredes G +4 more
europepmc +1 more source
Commission report to the Council on monitoring of Article 95 ECSC steel cases. SEC (94) 725 final, 31.05.1994 [PDF]
, 1994 core
MindRegulation-SEL: randomized controlled trial of the effects of a relaxation and guided imagery intervention with socioemotional learning on the psychological and biophysiological well-being, socioemotional development, cognitive function and academic achievement of elementary school children. [PDF]
TrialsGalinha IC +6 more
europepmc +1 more source
Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions. [PDF]
Eur J Neurol, 2019 Ferreira JJ +5 more
europepmc +1 more source
Bioequivalence of eslicarbazepine acetate from two different sources of its active product ingredient in healthy subjects. [PDF]
Drugs R D, 2013 Falcão A +4 more
europepmc +1 more source
Third-Generation Solid Dispersion Through Lyophilization Enhanced Oral Bioavailability of Resveratrol. [PDF]
ACS Pharmacol Transl SciAlmeida H +6 more
europepmc +1 more source
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease. [PDF]
Pharmaceuticals (Basel), 2019 Maia MA, Sousa E.
europepmc +1 more source
Design and Validation of a Laboratory-Scale System for Investigating Coking Byproducts. [PDF]
ACS OmegaManera C +5 more
europepmc +1 more source
Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453). [PDF]
Drugs R D, 2011 Vaz-da-Silva M +5 more
europepmc +1 more source